2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions

View by Date

Wednesday, September 25, 2019

1:15pm-2:45pm: Resting state Functional Connectivity differences in Pediatric Patients with Tourette syndrome and Obsessive-compulsive disorder

S. Tikoo, F. Cardona, S. Tommasin, C. Giannì, N. Upadhyay, K. Bharti, G. Conte, G. Mirabella, A. Suppa, P. Pantano (Roma, Italy)

Neuroimaging · Les Muses Terrace, Level 3

1:15pm-2:45pm: Resting-state EEG spectral power in Parkinson’s disease

J. Dalrymple-Alford, R. Shoorangiz, E. Petersen, R. Jones, B. Elias, L. Livingston, I. Kirk, L. Tippett, M. Livingstone, T. Anderson (Christchurch, New Zealand)

Cognition and Cognitive Disorders · Agora 3 East, Level 3

1:15pm-2:45pm: Restless legs syndrome in a patient with hereditary hemochromatosis

Z. Fatima, S. Wijemanne (San Antonio, TX, USA)

Phenomenology and Clinical Assessment of Movement Disorders · Les Muses Terrace, Level 3

1:15pm-2:45pm: Retinal layer thinning in de novo Parkinson’s disease

A. Chrysou, N. Jansonius, T. van Laar (Groningen, Netherlands)

Neuroimaging · Les Muses Terrace, Level 3

1:15pm-2:45pm: Retronasal olfactory function in Parkinson’s disease

E. Aubry-Lafontaine, C. Tremblay, P. Durand-Martel, N. Dupré, J. Frasnelli (Trois-Rivières, QC, Canada)

Non-Motor Symptoms · Agora 3 West, Level 3

1:15pm-2:45pm: Retrospective analysis of hospitalized Parkinson ‘s disease patients from 2002 to 2014 in Suzhou district

C. Mao, J. Chen, H. Gu, D. Chen, J. Huang, J. Chen, Y. Wang, W. Luo, C. Liu (Changshu, China)

Epidemiology · Les Muses, Level 3

1:15pm-2:45pm: Risk of developing the Parkinson’s disease against the background of diabetes mellitus type 2.

F. Akhmedova, M. Tukhtamishev (Tashkent, Uzbekistan)

Physiology and Pathophysiology · Les Muses, Level 3

1:15pm-2:45pm: RNA binding protein mediated regulation of striatal transcriptome in Parkinson’s disease.

K. Irmady, C. Hale, C. Scheckel, J. Fak, R. Darnell (New York, NY, USA)

Physiology and Pathophysiology · Les Muses, Level 3

1:15pm-2:45pm: Role of Alzheimer’s Disease Genetic Risk Variant rs9331896 in Cognitive Decline in Parkinson’s Disease

T. Tropea, L. Baratta, K. Maddy, M. Guo, J. Rick, V. van Deerlin, J. Trojanowski, D. Weintraub, A. Chen-Plotkin (Philadelphia, PA, USA)

Cognition and Cognitive Disorders · Agora 3 East, Level 3

1:15pm-2:45pm: Role of clinical neuroimaging in X-linked dystonia-parkinsonism

J. Junker, A. Neumann, R. Rosales, D. Jamora, C. Diesta, J. Prasuhn, T. Muente, C. Klein, P. Schramm, N. Brueggemann (Luebeck, Germany)

Neuroimaging · Les Muses Terrace, Level 3